Cancer treatment company plans for public offeringJuly 25, 2019PetCure Oncology has engaged Boustead Securities for a Regulation D 506(c) offering.
SPONSORED CONTENTLet's help them fight the urge to itchHill’s Derm Complete is formulated to help reduce allergic responses, including licking, scratching, headshaking and skin redness + Tell Me More